91 related articles for article (PubMed ID: 12399627)
1. Prognostic value of urinary interleukin 6 in patients with IgA nephropathy: an 8-year follow-up study.
Harada K; Akai Y; Kurumatani N; Iwano M; Saito Y
Nephron; 2002 Dec; 92(4):824-6. PubMed ID: 12399627
[TBL] [Abstract][Full Text] [Related]
2. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy.
Ranieri E; Gesualdo L; Petrarulo F; Schena FP
Kidney Int; 1996 Dec; 50(6):1990-2001. PubMed ID: 8943482
[TBL] [Abstract][Full Text] [Related]
3. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
Stangou M; Alexopoulos E; Papagianni A; Pantzaki A; Bantis C; Dovas S; Economidou D; Leontsini M; Memmos D
Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of urinary interleukin 6 in IgA nephropathy.
Dohi K; Iwano M; Muraguchi A; Horii Y; Hirayama T; Ogawa S; Shiiki H; Hirano T; Kishimoto T; Ishikawa H
Clin Nephrol; 1991 Jan; 35(1):1-5. PubMed ID: 2007290
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
Rauta V; Finne P; Fagerudd J; Rosenlöf K; Törnroth T; Grönhagen-Riska C
Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
Zwiech R; Kacprzyk F; Szuflet A; Nowicki M
Pol Arch Med Wewn; 2005 Apr; 113(4):326-33. PubMed ID: 16209246
[TBL] [Abstract][Full Text] [Related]
7. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
8. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
9. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
Zhao Y; Zhu L; Zhou T; Zhang Q; Shi S; Liu L; Lv J; Zhang H
PLoS One; 2015; 10(3):e0119033. PubMed ID: 25816025
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of NGAL staining in patients with IgA nephropathy.
Yavas H; Sahin OZ; Ersoy R; Taşlı F; Gibyeli Genek D; Uzum A; Cirit M
Ren Fail; 2013; 35(4):472-6. PubMed ID: 23413884
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
Stangou M; Papagianni A; Bantis C; Moisiadis D; Kasimatis S; Spartalis M; Pantzaki A; Efstratiadis G; Memmos D
Clin Nephrol; 2013 Sep; 80(3):203-10. PubMed ID: 23611517
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
Peters HP; van den Brand JA; Wetzels JF
Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
[TBL] [Abstract][Full Text] [Related]
13. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.
Torres DD; Rossini M; Manno C; Mattace-Raso F; D'Altri C; Ranieri E; Pontrelli P; Grandaliano G; Gesualdo L; Schena FP
Kidney Int; 2008 Feb; 73(3):327-33. PubMed ID: 17943082
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
[TBL] [Abstract][Full Text] [Related]
15. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.
Kalliakmani P; Nakopoulou L; Tsakas S; Gerolymos M; Papasotiriou M; Goumenos DS
Clin Nephrol; 2011 Aug; 76(2):144-50. PubMed ID: 21762647
[TBL] [Abstract][Full Text] [Related]
16. Significance of urinary full-length megalin in patients with IgA nephropathy.
Seki T; Asanuma K; Asao R; Nonaka K; Sasaki Y; Oliva Trejo JA; Kurosawa H; Hirayama Y; Horikoshi S; Tomino Y; Saito A
PLoS One; 2014; 9(12):e114400. PubMed ID: 25502002
[TBL] [Abstract][Full Text] [Related]
17. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
[TBL] [Abstract][Full Text] [Related]
18. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy.
Eiro M; Katoh T; Kuriki M; Asano K; Watanabe K; Watanabe T
Nephron; 2002 Apr; 90(4):432-41. PubMed ID: 11961402
[TBL] [Abstract][Full Text] [Related]
19. Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy.
Tomino Y; Funabiki K; Ohmuro H; Shimizu M; Yokoyama K; Shirato I; Shirai T; Takahashi M; Koide H
Am J Nephrol; 1991; 11(6):459-64. PubMed ID: 1819212
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
Sugawara K; Takeda K; Nakai K; Takahashi N; Adachi T; Fukuda T; Miura S
Nihon Jinzo Gakkai Shi; 2008; 50(8):1017-23. PubMed ID: 19172803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
